Search clinical trials for: Risedronic acid

Total 23726 results

Warner Chilcott
Sanofi

Completed

A Study of Monthly Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Brazil, France, Spain, Hungary, Poland, Finland, Norway, Belgium, Argentina, Estonia, Lebanon, Canada, Australia
Warner Chilcott
Sanofi

Completed

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects

Osteoporosis

United States
Institut National de la Santé Et de la Recherche...
Charite University, Berlin, Germany; Cliniques universitaires Saint-Luc- Université... and other collaborators

Completed

Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone (PROFIDYS)

Fibrous Dysplasia of Bone

Belgium, France, Germany, Netherlands
Warner Chilcott
Sanofi

Completed

Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate

Bioavailability

United States
Warner Chilcott

Completed

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Postmenopausal Women

United States
Warner Chilcott
Sanofi

Completed

Food Effects on the Relative Bioavailability of Different Dosages of Risedronate

Postmenopausal | Non-lactating | Surgically Sterile

United States
Warner Chilcott
Sanofi

Completed

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Postmenopausal

United States, Poland, Canada, Croatia, Netherlands
Warner Chilcott

Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Estonia, Hungary, Poland, Canada, France, Argentina, Belgium
Warner Chilcott

Completed

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Postmenopausal Women With Osteoporosis

Spain, Australia, Belgium, Denmark, Finland, Italy, Poland, Sweden
Sanofi
Procter and Gamble

Completed

Risedronate in Osteopenic Postmenopausal Women (OSMAUSE)

Osteoporosis

France
Hoffmann-La Roche

Completed

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Post Menopausal Osteoporosis

United States
Montefiore Medical Center

Completed

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

Renal Transplant Osteodystrophy

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Paget's Disease of Bone

United States, Germany, Spain, United Kingdom, Canada, France, Belgium, South Africa, Australia, New Zealand
Sanofi
Procter and Gamble

Completed

Risedronate in Postmenopausal Women With Low Bone Density

OSTEOPOROSIS, POSTMENOPAUSAL
Warner Chilcott
Sanofi

Completed

Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Osteoporosis

United States, Canada
UConn Health
Proctor and Gamble/Aventis

Completed

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Prostate Cancer

United States
CMX Research
Sanofi

Completed

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

Prostate Cancer

Canada
Sanofi
Procter and Gamble

Completed

IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)

Osteoporosis
Sanofi

Completed

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis (ROSPA-CTx)

Osteoporosis, Postmenopausal
Takeda

Completed

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

Osteoporosis

Japan
University Hospital, Limoges

Terminated

Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis (PTH)

Prosthesis Loosening

France
Warner Chilcott
Sanofi

Completed

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Postmenopausal Osteoporosis

Australia, Italy, Poland, Spain, Sweden
Toronto Rehabilitation Institute
The Physicians' Services Incorporated Foundation; St. Joseph's Health Care...

Completed

Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury

Osteoporosis

Canada
Sanofi
Procter and Gamble

Terminated

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Osteoporosis

Israel
Tuen Mun Hospital

Completed

The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment

Osteoporosis

China
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Procter and Gamble

Completed

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Post-menopausal Osteoporosis

United Kingdom
Warner Chilcott
Sanofi

Completed

Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food

Healthy

United States
University Hospitals Cleveland Medical Center

Withdrawn

Effect of Actonel on Periodontal Health of Postmenopausal Women

Periodontal Disease

United States
Warner Chilcott
Sanofi

Completed

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Other Osteoporosis

United Kingdom, United States, Poland, France, Hungary, Netherlands, Czech Republic, Lebanon, Australia, Belgium
Toronto Rehabilitation Institute
Ontario Neurotrauma Foundation; Queen Elizabeth Hospital NHS Foundation Trust; St. Joseph's Healthcare Foundation

Completed

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

Acute Spinal Cord Injury.

Canada
University of Nebraska
National Institute of Nursing Research (NINR)

Completed

Prevention of Osteoporosis in Breast Cancer Survivors

Postmenopausal Osteoporosis

United States
Warner Chilcott

Completed

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Osteopenia

United Kingdom, Argentina, Australia, Canada, France, Germany, Switzerland
Sanofi
Procter and Gamble

Completed

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Osteoporosis Postmenopausal

France, United States, Australia, Canada, Lebanon, South Africa, Czech Republic, Turkey, Argentina, Poland, United Kingdom
Eli Lilly and Company

Completed

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

Back Pain | Osteoporosis, Postmenopausal | Spinal Fracture

Italy, Mexico, Australia, United States, Germany, Belgium, Puerto Rico, Sweden, Brazil, France, Canada, Spain, Argentina
Christopher Sweeney, MBBS
Sanofi; Hoosier Cancer Research Network; Walther Cancer Institute

Terminated

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Metastatic Prostate Cancer

United States, Canada
Sanofi
Procter and Gamble

Completed

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Osteoporosis, Postmenopausal

United States
Novartis Pharmaceuticals

Completed

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Paget's Disease of Bone

United States, United Kingdom, Canada, New Zealand, Spain, Australia
Warner Chilcott
Sanofi

Terminated

Bone Microarchitecture in Osteopenic Postmenopausal Women

Osteoporosis

United States, Argentina
Sanofi
Procter and Gamble

Completed

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

Osteoporosis, Postmenopausal

Netherlands, Sweden, Finland, Spain, Norway
Brigham and Women's Hospital

Completed

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Osteoporosis

United States
Mahidol University

Unknown

Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty

Femoral Neck Fracture | Osteoporotic Fractures

Thailand
Danderyd Hospital
Sanofi

Completed

Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty (PREVENT)

Bone Loss

Sweden
Sanofi
Procter and Gamble

Completed

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Osteoporosis, Postmenopausal

United States, Netherlands, Australia, Belgium, Canada, France, United Kingdom
Sanofi
Procter and Gamble

Completed

Risedronate Sodium in Post Menopausal Osteoporosis

Osteoporosis, Postmenopausal

Turkey
Sanofi

Completed

Satisfaction and Compliance of Risedronate in PMO

Osteoporosis, Postmenopausal

Korea, Republic of
M.D. Anderson Cancer Center
Procter and Gamble

Completed

A Study of Actonel for the Prevention of Bone Loss

Lymphoma | Leukemia

United States
Takeda

Completed

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

Osteoporosis

Japan
Hospices Civils de Lyon

Completed

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer (RISAROS)

Breast Cancer | Menopause | Osteopenia

France
Warner Chilcott
Sanofi

Completed

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Osteoporosis | Osteopenia

United States
Amgen

Completed

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Osteoporosis

Search clinical trials for: Risedronic acid

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations